Skip to main content

Table 1 Trial management

From: A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design

Trial Operations Committee

 

Adnan Tufail

Chief Investigator, Moorfields Eye Hospital, London, UK

Praveen J Patel

Principal Investigator, Moorfields Eye Hospital, London, UK

Laura Henderson (Mrs Ola Segun-Odumosu from March 2008)

Trial Manager, Moorfields Eye Hospital, London, UK

Trial Steering Committee

 

Astrid Fletcher

Professor of Epidemiology and Ageing, London School of Hygiene and Tropical Medicine, London, UK

Adnan Tufail

Chief Investigator, Moorfields Eye Hospital, London, UK

Catey Bunce

Trial Statistician, Moorfields Eye Hospital, London, UK

Praveen J Patel

Principal Investigator, Moorfields Eye Hospital, London, UK

Richard Wormald

Consultant Ophthalmologist, Moorfields Eye Hospital, London, UK

Data Monitoring Committee

 

Catey Bunce

Trial Statistician, Moorfields Eye Hospital, London, UK

Marion Campbell

Professor of Health Services Research, University of Aberdeen, UK

Robyn Guymer

Professor of Ophthalmology, University of Melbourne, Australia

Frank G. Holz

Professor of Ophthalmology, University of Bonn, Germany